Mobile Menu

Search Results

Search results for: Precision Oncology

Precision Oncology ONLINE – September 2022

Join us for this unique three-part webinar series, Precision Oncology ONLINE, as we delve into how detecting rare sequences can […]

Precision Oncology ONLINE – 2021 Edition

Imagine a world where nearly every cancer patient was diagnosed early, at a treatable stage, had access to targeted therapies […]

Evaluation of ctDNA assays for precision oncology

An international team has reported findings from an independent assessment of five commercially available ctDNA assays as a method to […]

Precision Oncology ONLINE: From preanalytical considerations to digital insights

Cancer is the world’s second biggest killer. In 2018, cancer claimed the lives of an estimated 9.6 million people. Needless […]

New class of precision oncology drug strips cancer of its DNA defences

Damage to the DNA in cells is the root cause of cancer, but it is also a weakness of the […]

Whole genome, whole exome or panel sequencing in precision oncology clinical trials

With a wealth of genomic technologies rapidly advancing with falling cost, implementing genomics into trials and routine care is becoming […]

Interview with Dr Susie Cooke, Head of Medical Genomics at the Glasgow Precision Oncology Laboratory

Dr Susie Cooke is the Head of Medical Genomics at the Glasgow Precision Oncology Laboratory whose main interest is in facilitating the move of next-generation sequencing into the clinic to help cancer patients.

Pan-cancer tumour organoids pave the way towards precision medicine

Researchers have developed a platform of pan-cancer tumour organoids and a neural-network-based drug assay, that has the potential to advance […]

Promises and pitfalls of precision medicine clinical trials, now and in the future.

As we move towards an ever more personalised healthcare system, genomics is at the heart of what makes an individual […]

Interview with CRUK: Promises and pitfalls of precision medicine clinical trials

Ahead of our virtual panel discussion on the promises and pitfalls of precision medicine trials: now and in the future […]